Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-24 @ 9:47 PM
NCT ID:
NCT00116532
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of OCD by DSM-IV
* Age 18-65
* Y-BOCS greater than 20
* Written informed consent
* Females of childbearing potential must have a negative serum or urinary beta-HCG test.
Exclusion Criteria:
* Pregnant women or women of childbearing potential who are not using a medically accepted means of contraception.
* Patients who, in the investigator's judgement, pose a serious suicidal or homicidal risk.
* Serious or unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, neurologic, or hematologic disease. Patients on anticoagulant therapy.
* History of seizure disorder
* Comorbid bipolar disorder, psychosis, organic mental disorder, or developmental disorder
* If there is a history of substance abuse, patients in remission at least 6 months.
* Currently being treated with behavioral therapy, specifically exposure and response prevention, for OCD.
* Other medications for medical disorders that may interfere with escitalopram
* Current major depression or prescribed an antidepressant for major depression within the past 12 months.
* Taken an SSRI medication within 2 weeks of beginning the study (4 weeks for fluoxetine).
* More than 1 adequate trial (at least 10 weeks at maximally tolerated dose) with another SSRI in the past.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00116532
Study Brief:
Protocol Section:
NCT00116532